P57 | MELFLUFEN IS EFFECTIVE AND SAFE IN MULTIPLE MYELOMA PATIENTS WITH SEVERE RENAL IMPAIRMENT
Multiple myeloma (MM) is often complicated with renal insufficiency (RI) which adversely influences the prognosis. The incidence of RI in MM patients ranges from 20% to 50% and is primarily due to light chains deposition in the kidney. Melphalan flufenamide (melflufen) is an anti-myeloma drug appro...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Ferrata Storti Foundation
2026-04-01
|
| Saila: | Haematologica |
| Sarrera elektronikoa: | https://haematologica.org/article/view/14084 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|